Related Experiment Video
Updated: Jan 27, 2026
10:52
Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
5.7K
PFO closure: Where are the neurologists?
1Heart Institute, Geisinger Health System, Danville, Pennsylvania.
Summary
Closure of patent foramen ovale (PFO) reduces recurrent stroke by 2% but increases atrial fibrillation risk. Current guidelines for PFO closure are outdated based on new meta-analysis findings.
Area of Science:
- Cardiology
- Neurology
- Interventional Cardiology
Background:
- A meta-analysis evaluated patent foramen ovale (PFO) closure versus medical therapy for recurrent stroke prevention.
- Five randomized controlled trials were included, comparing procedural closure with non-invasive treatments.
Discussion:
- PFO closure demonstrated a statistically significant 2% absolute reduction in recurrent stroke events.
- No significant difference in mortality was observed between the PFO closure and medical therapy groups.
- An absolute 2% increase in atrial fibrillation, typically transient, and minor procedural complications were noted post-PFO closure.
Key Insights:
- Patent foramen ovale closure offers a modest but significant benefit in preventing recurrent strokes.
- The risks associated with PFO closure, including atrial fibrillation and procedural complications, must be carefully weighed against the benefits.
- Existing clinical guidelines for PFO closure require revision in light of this updated evidence.
Outlook:
- Further research may refine patient selection criteria for PFO closure to optimize outcomes.
- Long-term data on the durability of PFO closure and its impact on stroke recurrence are warranted.
- This meta-analysis provides critical data for updating clinical practice guidelines regarding PFO closure for stroke prevention.
